NORTHWEST BIOTHERAPEUTICS INC Payments to Acquire in Process Research and Development
NORTHWEST BIOTHERAPEUTICS INC (NWBO) reported Payments to Acquire in Process Research and Development of $49.10 million for the 6-month period ending 2015-06-30, per its 10-Q filed 2015-08-10.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInProcessResearchAndDevelopment · last filed 2015-08-10
- NORTHWEST BIOTHERAPEUTICS INC payments to acquire in process research and development for the quarter ending 2015-06-30 was $29.40M, a 36.74% increase year-over-year.
- NORTHWEST BIOTHERAPEUTICS INC payments to acquire in process research and development for the quarter ending 2015-03-31 was $19.70M, a 1.50% decline year-over-year.
- NORTHWEST BIOTHERAPEUTICS INC payments to acquire in process research and development for the quarter ending 2014-12-31 was $40.20M, a 255.75% increase year-over-year.
- NORTHWEST BIOTHERAPEUTICS INC payments to acquire in process research and development for the quarter ending 2014-09-30 was $14.70M, a 15.29% increase year-over-year.
- NORTHWEST BIOTHERAPEUTICS INC payments to acquire in process research and development for fiscal 2014 was $85.60M, a 94.99% increase from fiscal 2013.
- NORTHWEST BIOTHERAPEUTICS INC payments to acquire in process research and development for fiscal 2013 was $43.90M.
| Period end | Payments to Acquire in Process Research and Development 3 month | Payments to Acquire in Process Research and Development 6 month | Payments to Acquire in Process Research and Development 9 month | Payments to Acquire in Process Research and Development 12 month |
|---|---|---|---|---|
| 2015-06-30 | $29.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $49.10M 10-Q · filed 2015-08-10 | $89.30M derived: sum of 3 quarters · filed 2015-08-10 | $104.00M derived: sum of 4 quarters · filed 2015-08-10 |
| 2015-03-31 | $19.70M 10-Q · filed 2015-05-11 | $59.90M derived: sum of 2 quarters · filed 2015-05-11 | $74.60M derived: sum of 3 quarters · filed 2015-05-11 | $96.10M derived: sum of 4 quarters · filed 2015-08-10 |
| 2014-12-31 | $40.20M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-17 | $54.90M derived: sum of 2 quarters · filed 2015-03-17 | $76.40M derived: sum of 3 quarters · filed 2015-08-10 | $85.60M 10-K · filed 2015-03-17 |
| 2014-09-30 | $14.70M 10-Q · filed 2014-11-19 | $36.20M derived: sum of 2 quarters · filed 2015-08-10 | $45.40M 10-Q · filed 2014-11-19 | $67.50M derived: sum of 4 quarters · filed 2015-08-10 |
| 2014-06-30 | $21.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $41.50M 10-Q · filed 2015-08-10 | $52.80M derived: sum of 3 quarters · filed 2015-08-10 | $65.55M derived: sum of 4 quarters · filed 2015-08-10 |
| 2014-03-31 | $20.00M 10-Q · filed 2015-05-11 | $31.30M derived: sum of 2 quarters · filed 2015-05-11 | $44.05M derived: sum of 3 quarters · filed 2015-05-11 | |
| 2013-12-31 | $11.30M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-17 | $24.05M derived: sum of 2 quarters · filed 2015-03-17 | $43.90M 10-K · filed 2015-03-17 | |
| 2013-09-30 | $12.75M 10-Q · filed 2014-11-19 | $32.60M 10-Q · filed 2014-11-19 |